TrialBMC oral health2026

Evaluation of D&C Red No. 33 as an alternative to erythrosine for plaque disclosure: a randomized crossover trial.

Sireerat Sooampon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.